From NBCSports.com, via the Associated Press:
A person with knowledge of the situation tells The Associated Press that Miami’s baseball team has been tested for performance-enhancing drug use, including human growth hormone.
Results have not arrived, according to the person, who spoke on condition of anonymity because the university has not authorized the information’s release. Miami’s drug policy includes random steroid testing, but not HGH.
The team’s strength coach, Jimmy Goins, showed up in the records of the Miami-based Biogenesis clinic along with the names of many former University of Miami players who have since moved on to the major leagues. The Hurricanes open their season this weekend with a three-game series against Rutgers.
The Twins have reportedly signed free agent shortstop Erick Aybar to a minor-league deal, LaVelle E. Neal III of the Star Tribune reported Friday. FanRag Sports’ Jon Heyman adds that the deal comes with a potential $1.25 million if Aybar reaches the majors, with additional incentives based on plate appearances. He’ll be able to opt out on March 27. The team has yet to confirm the signing.
Aybar, 34, is now four years removed from his career year in 2014. He’s been in a state of steady decline since then, slashing just .234/.300/.348 with seven home runs and 11 stolen bases over 370 plate appearances for the Padres in 2017. His poor performance wasn’t helped by a fractured left foot, either, which cost him almost six weeks on the disabled list.
Still, the Twins see something promising in the veteran infielder, and reportedly intend to use him as another utility option this spring. Per Neal, Aybar will join fellow backup infielders Eduardo Escobar and Ehire Adrianza and may even (temporarily) take over for Miguel Sano at third base if Sano isn’t able to shape up for the role by Opening Day.